Chevron Corporation CVX has entered the second half of 2026 with considerable operating momentum. The company recently delivered an impressive quarterly beat, reporting adjusted earnings of $12 billion for the second quarter of 2026. The strong performance was supported by solid operational execution, higher crude oil price realizations, robust refining margins and increased production following the Hess acquisition.
Results were further underpinned by stronger cash flow, a resilient upstream portfolio and disciplined shareholder returns. Yet with shares lagging both ExxonMobil XOM and Shell SHEL, and valuation sitting at a premium, the bigger question is whether this momentum can translate into meaningful upside for investors.
Strong Production and Cash Generation Support CVX
Chevron’s second-quarter operating performance was impressive. Worldwide net oil-equivalent production reached 4.07 million barrels per day, up 20% year over year, driven largely by legacy Hess assets and growth in the Permian Basin and Gulf of America. U.S. production reached a record 2.07 million barrels of oil equivalent per day. Refining operations were similarly strong, with U.S. crude unit throughput reaching a record 1.07 million barrels per day and utilization exceeding 97%.
Higher commodity prices amplified those operating gains. Chevron reported second-quarter earnings of $12.1 billion, or $6.11 per share, while adjusted earnings totaled roughly $12 billion, or $6.06 per share. Cash flow from operations excluding working capital was $19.7 billion, while adjusted free cash flow reached $15.4 billion.
That cash generation has provided significant financial flexibility. Chevron reduced debt by a record $8.4 billion during the quarter, while its net debt-to-CFFO ratio improved to 0.6X. At the same time, the company continued returning capital, paying $3.5 billion of dividends and repurchasing $3 billion of shares during the quarter.
Â

Image Source: Chevron Corporation
Hess Integration and Cost Savings Strengthen the Story
The Hess acquisition is also showing tangible benefits. One year after closing, Chevron had captured $1.5 billion of annual run-rate synergies — 50% above its initial target and six months ahead of schedule. Management said the acquired assets are generating free cash flow at roughly twice the incremental dividend burden, while Guyana provides exposure to high-margin production growth extending into the 2030s.
Cost discipline offers another lever. Chevron achieved $3 billion of annual run-rate structural cost reductions six months early, with more than 70% of the savings stemming from efficiency improvements. Meanwhile, management expects 2026 shale and tight capital spending per barrel of oil equivalent to be 25% below last year, indicating that production growth is becoming more capital efficient.
Chevron is also broadening its opportunity set beyond conventional oil and gas. Project Kilby in West Texas includes a 20-year take-or-pay agreement to supply Microsoft with 2.67 gigawatts of behind-the-meter power. Management expects the project to generate mid-teens returns and long-duration cash flows that are less correlated with commodity cycles, although the project remains subject to final investment decision and execution.
What Could Hold Chevron Back?
Commodity exposure remains the biggest swing factor. Chevron estimates that every $1 change in Brent affects full-year after-tax earnings and cash flow by roughly $600 million. Second-quarter Brent averaged nearly $104 per barrel, providing a substantial earnings tailwind that may not persist.

Image Source: Chevron Corporation
Near-term operations also face maintenance headwinds. Chevron expects third-quarter upstream turnarounds and downtime to reduce production by 150,000-200,000 barrels of oil equivalent per day, while downstream maintenance could reduce after-tax earnings by $175-$225 million. Geopolitical exposure, particularly around Kazakhstan’s CPC export route and the Middle East, adds another layer of uncertainty. The company itself identifies commodity prices, OPEC+ actions, geopolitical conflicts and operational disruptions among material risks.
CVX’s Price Performance & Valuations
Chevron’s shares have gained 1% over the past three months compared with the sub-industry’s 0.3% growth. However, the company underperformed its peers, as ExxonMobil and Shell have risen 2.2% and 3.7%, respectively, during the same time period.

Image Source: Zacks Investment Research
Chevron’s premium valuation also leaves less room for error. The stock trades at roughly a 12.61X forward price-to-earnings multiple, notably higher than Shell’s 9.44X but below ExxonMobil’s 13.32X.
Valuation Comparison

Image Source: Zacks Investment Research
CVX Merits a Balanced View
Chevron’s underlying picture is constructive: record production, accelerating Hess synergies, structural cost reductions, robust cash generation and a stronger balance sheet provide a solid foundation. The Microsoft power agreement also introduces an intriguing source of contracted, commodity-diversified growth.
However, elevated commodity sensitivity and upcoming maintenance could create earnings volatility after an exceptionally strong second quarter. For now, Chevron, currently carrying a Zacks Rank #3 (Hold), appears well positioned operationally, but investors may want clearer evidence that recent earnings strength can endure through a less supportive commodity environment before taking a more bullish stance.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Â
Â
Â

(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.